Unique ID issued by UMIN | UMIN000022352 |
---|---|
Receipt number | R000025250 |
Scientific Title | Effect of a plant-derived processed food on fat metabolism |
Date of disclosure of the study information | 2016/05/19 |
Last modified on | 2019/07/31 09:56:08 |
Effect of a plant-derived processed food on fat metabolism
Effect of a plant-derived processed food on dietary fat oxidation
Effect of a plant-derived processed food on fat metabolism
Effect of a plant-derived processed food on dietary fat oxidation
Japan |
Healthy subjects
Adult |
Others
NO
To investigate the effect of a plant-derived processed food on fat metabolism.
Efficacy
Confirmatory
Fat oxidation measures after 1wk repeated ingestion
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Treatment
Food |
Ingestion of test diet (code name: A-004) for 1 weeks > wash out more than 1 weeks > Ingestion of control diet (code name: C-004) for 1 weeks.
dose: one serving size per day
Energy metabolism will be measured after 1wk repeated ingestion
Ingestion of control diet (code name: C-004) for 1 weeks > wash out more than 1 weeks > Ingestion of test diet (code name: A-004) for 1 weeks.
dose: one serving size per day
Energy metabolism will be measured after 1wk repeated ingestion
35 | years-old | <= |
65 | years-old | > |
Male and Female
1, Aged between 35 and 64
2, BMI >= 23 and <30 kg/m2
3, Person who provides informed consent by a document
1, Hepatic, renal, or cardiac diseases, respiratory impairment, endcrinopathy, metabolic impairment, neuropathy, impaired mental status, diabetes, other disorders that would make participation in a study difficult
2, Surgery for disease or injury within 2 months before the study
3, Treatment with medication to improve glucose metabolism, fat metabolism, or blood pressure
4, Regular consumption Food with Health Claims (Food for Specified Health Uses [FOSHU], Foods with functional Claims, and nutritional food supplements) and supplements
5, Individual experienced unpleasant feeling during blood drawing.
6, Donation of 200mL or more of blood within 1month before the study
7, Heavy smoker (21 cigarettes a day or more)
8, Inability to continuous administration in the test diets
9, Potential to exhibit allergic symptoms to the ingredients in the test diets
10, Shift-worker
11, Intention to live or travel overseas for an extended period (6 or more consecutive days) during the study period (including wash-out periods)
12, Inability to record a diet for 9 days (3 days x 3 times)
13, Lock of consent to view previous medical records
14, Current participation in another clinical study or who intended to participate in one during the study period
15, Person who are considered inappropriate by medical doctors.
20
1st name | |
Middle name | |
Last name | Takahiro Ono |
MEDICS Hongo Clinic
Director
2-2-6 Mukogaoka, Bunkyo-ku, Tokyo
03-6801-9761
info@tes-h.co.jp
1st name | |
Middle name | |
Last name | Ryoma Shimizu |
TES Holdings Co. Ltd
Administrative Department of Clinical Trials
6F University of Tokyo Entrepreneur Plaza 7-3-1 Hongo Bunkyo-ku Tokyo 113-0033, JAPAN
03-6801-8480
r.shimizu@tes-h.co.jp
MEDICS Hongo Clinic
Kao Corporation
Profit organization
NO
2016 | Year | 05 | Month | 19 | Day |
Unpublished
Completed
2016 | Year | 04 | Month | 18 | Day |
2016 | Year | 05 | Month | 19 | Day |
2016 | Year | 05 | Month | 19 | Day |
2019 | Year | 07 | Month | 31 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025250